Science Explorer Back to mapMap

Most cited papers from Johannes Wesling Klinikum Minden

What are the most cited papers from Johannes Wesling Klinikum Minden?

The most cited paper from Johannes Wesling Klinikum Minden is "ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment" (Joana Torres et al., 2019), with 1,378 citations. Next come "ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment" (1,128) and "Risk Factors, Outcome, and Treatment in Subtypes of Ischemic Stroke: The German Stroke Data Bank" (1,012).

Showing 50 of 60 papers. Every paper with more than 163 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment Joana Torres et al. · Journal of Crohn s and Colitis Open access 2 Nov 2019 1,378
2 ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment Michel Adamina et al. · Journal of Crohn s and Colitis Open access 15 Nov 2019 1,128
3 Risk Factors, Outcome, and Treatment in Subtypes of Ischemic Stroke: The German Stroke Data Bank Armin Grau, Christian Weimar, Florian Buggle et al. · Stroke Nov 2001 1,012
4 Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke Gregory J. del Zoppo, Klaus Poeck, Michael S. Pessin et al. · Annals of Neurology Jul 1992 1,004
5 Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera Alessandro Maria Vannucchi, Jean‐Jacques Kiladjian, Martin Grießhammer et al. · New England Journal of Medicine Open access 28 Jan 2015 893
6 Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source Hans‐Christoph Diener et al. · New England Journal of Medicine Open access 15 May 2019 833
7 Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial Ulrike Leiter, Rudolf Stadler, Cornelia Mauch et al. · The Lancet Oncology 6 May 2016 710
8 Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial Henry Miles Prince et al. · The Lancet 7 Jun 2017 593
9 European Stroke Organisation (ESO) – European Society for Minimally Invasive Neurological Therapy (ESMINT) Guidelines on Mechanical Thrombectomy in Acute Ischaemic StrokeEndorsed by Stroke Alliance for Europe (SAFE) Guillaume Turc, Pervinder Bhogal, Urs Fischer et al. · European Stroke Journal Open access 26 Feb 2019 584
10 Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet Tiziano Barbui et al. · Leukemia Open access 27 Feb 2018 569
11 Anticoagulant Reversal, Blood Pressure Levels, and Anticoagulant Resumption in Patients With Anticoagulation-Related Intracerebral Hemorrhage Joji B. Kuramatsu et al. · JAMA 24 Feb 2015 568
12 Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity Christian Joerg Braun et al. · Science Translational Medicine Open access 12 Mar 2014 561
13 European Stroke Organisation (ESO)- European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischemic stroke Guillaume Turc, Pervinder Bhogal, Urs Fischer et al. · Journal of NeuroInterventional Surgery 31 May 2019 477
14 Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs Robyn M. Emanuel et al. · Journal of Clinical Oncology Open access 16 Oct 2012 465
15 European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017 Franz Trautinger, Johanna Eder, Chalid Assaf et al. · European Journal of Cancer Open access 31 Mar 2017 452
16 Self-Expanding Metal Stents for Gastroduodenal Malignancies: Systematic Review of their Clinical Effectiveness Arno Josef Dormann, Søren Meisner, Nathalie Verin et al. · Endoscopy Jun 2004 443
17 EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome Franz Trautinger, Robert Knobler, Rein Willemze et al. · European Journal of Cancer Open access 31 Mar 2006 417
18 Imaging of acute stroke Keith W. Muir, Alastair Mitchell Buchan, Rüdiger von Kummer et al. · The Lancet Neurology 18 Aug 2006 366
19 Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry Mark J. Alberts, Deepak L. Bhatt, Jean Louis Mas et al. · European Heart Journal Open access 31 Aug 2009 333
20 European Stroke Organisation and European Society for Swallowing Disorders guideline for the diagnosis and treatment of post-stroke dysphagia Rainer Dziewas, Emilia Michou, Michaela Trapl‐Grundschober et al. · European Stroke Journal Open access Sep 2021 324
21 The REduction of Atherothrombosis for Continued Health (REACH) Registry: An international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design E. Magnus Ohman, Deepak L. Bhatt, Philippe Gabríel Steg et al. · American Heart Journal 29 Mar 2006 309
22 Hemoadsorption by CytoSorb in septic patients: a case series Klaus Kogelmann, Dominik Jarczak, Morten Scheller et al. · Critical Care Open access 21 Mar 2017 304
23 Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD Richard F. Schlenk et al. · Blood Open access 18 Dec 2018 290
24 Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group Nicolaus Martin Kröger et al. · Leukemia 21 Aug 2015 278
25 Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference Giovanni Barosi, Gunnar Birgegård, Guido Finazzi et al. · Blood Open access 10 Mar 2009 267
26 Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study Francesco Passamonti, Martin Grießhammer, Francesca Palandri et al. · The Lancet Oncology Dec 2016 260
27 Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis Shinya Goto, Deepak L. Bhatt, Joachim A. Rother et al. · American Heart Journal 24 Sep 2008 260
28 Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry P. Cacoub, Maria Teresa B. Abola, Iris Baumgärtner et al. · Atherosclerosis Nov 2008 256
29 Development of Type 1 Diabetes despite Severe Hereditary B-Cell Deficiency Stéphan Martin, Dorothea Wolf-Eichbaum, Gaby Duinkerken et al. · New England Journal of Medicine Open access 4 Oct 2001 253
30 Prediction of malignant middle cerebral artery infarction by magnetic resonance imaging within 6 hours of symptom onset: A prospective multicenter observational study Götz Thomalla, Frank Hartmann, Eric Jüettler et al. · Annals of Neurology 23 Sep 2010 250
31 An International Model to Predict Recurrent Cardiovascular Disease Peter W.F. Wilson, Ralph B. D’Agostino, Deepak L. Bhatt et al. · The American Journal of Medicine Open access 20 Jun 2012 249
32 European Guideline on IgG4‐related digestive disease – UEG and SGF evidence‐based recommendations Matthias J. Löhr et al. · United European Gastroenterology Journal Open access 18 Jun 2020 248
33 Guidelines on the use of extracorporeal photopheresis Robert Knobler et al. · Journal of the European Academy of Dermatology and Venereology Open access 19 Dec 2013 221
34 Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID) Hans‐Peter Tony et al. · Arthritis Research & Therapy Open access 13 May 2011 212
35 Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial Brett G.M. Hughes, E. Munoz-Couselo, Laurent Mortier et al. · Annals of Oncology Open access 20 Jul 2021 208
36 Leukoaraiosis Is a Risk Factor for Symptomatic Intracerebral Hemorrhage After Thrombolysis for Acute Stroke Tobias Neumann‐Haefelin, Silke Hoelig, Joachim Berkefeld et al. · Stroke Open access 25 Aug 2006 201
37 Assessment of Functioning and Disability After Ischemic Stroke Christian Weimar, Tobias Kurth, Klaus Kraywinkel et al. · Stroke Open access Aug 2002 199
38 Cost‐of‐illness of chronic leg ulcers in Germany Sandra Purwins, Katharina Herberger, E. Sebastian Debus et al. · International Wound Journal Open access Apr 2010 197
39 Surgical and medical management of patients with massive cerebellar infarctions: results of the German-Austrian Cerebellar Infarction Study Marek Jauß, Don Krieger, Claus R. Hornig et al. · Journal of Neurology 29 Apr 1999 194
40 Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data Götz Thomalla et al. · The Lancet ReviewOpen access815 authors Nov 2020 192
41 The Essen Stroke Risk Score Predicts Recurrent Cardiovascular Events Christian Weimar, Hans‐Christoph Diener, Mark J. Alberts et al. · Stroke 20 Nov 2008 192
42 Vedolizumab induction therapy for inflammatory bowel disease in clinical practice – a nationwide consecutive German cohort study Daniel C. Baumgart, Bernd Bokemeyer, Attyla Drabik et al. · Alimentary Pharmacology & Therapeutics Apr 2016 189
43 Degradation of cationic and anionic dyes in coagulation–flocculation process using bi-functionalized silica hybrid with aluminum-ferric as auxiliary agent Yen-Yie Lau, Yee‐Shian Wong, Tjoon Tow Teng et al. · RSC Advances 2015 187
44 Association of Surgical Hematoma Evacuation vs Conservative Treatment With Functional Outcome in Patients With Cerebellar Intracerebral Hemorrhage Joji B. Kuramatsu et al. · JAMA Open access 8 Oct 2019 186
45 Randomised trial of single and repeated fibrin glue compared with injection of polidocanol in treatment of bleeding peptic ulcer Paul J. Rutgeerts, Erik A.J. Rauws, Pål Wara et al. · The Lancet Sep 1997 186
46 Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: Results of a prospectively randomised Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN) DGCIN – German Cooperative Renal Carcinoma Chemo-Immunotherapy Trials Group, Jens Atzpodien, E. Schmitt et al. · British Journal of Cancer Open access Mar 2005 186
47 Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban Thorsten Steiner, Michael C Böhm, Martin Dichgans et al. · Clinical Research in Cardiology 13 May 2013 183
48 European Neuroendocrine Tumor Society ( ENETS ) 2023 guidance paper for gastroduodenal neuroendocrine tumours ( NETs) G1–G3 Francesco Panzuto, John Keith Ramage, David Mark Pritchard et al. · Journal of Neuroendocrinology Open access 20 May 2023 181
49 Risk of Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis in Patients With Acute Ischemic Stroke and High Cerebral Microbleed Burden Georgios K. Tsivgoulis, Ramin Zand, Aristeidis H. Katsanos et al. · JAMA Neurology Open access 18 Apr 2016 181
50 Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC Elise A. Olsen et al. · Blood Open access 11 Nov 2021 180

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.